ZEGFROVY is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 ...

Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance .bwalignc { text-align: center; ...

When you are concerned about gray hair on your nape or nape line, it is recommended that you first check how much is visible ...

When red bumps that look like acne or pimples appear on the nape of your neck, it becomes impossible to tell if they are acne ...

Sanofi will now work with provincial, territorial and federal drug programs to support access to the treatment for eligible ...

Dupixent is also indicated as an add-on maintenance treatment with intranasal corticosteroids in adult patients with severe ...

Aurobindo Pharma launched ADQUEY in the US to treat atopic dermatitis. Learn about this specialty drug move, Q1 financials, ...

Boston biotech Bambusa files for Nasdaq IPO (BBTX) to fund eczema and inflammation trials, backed by RA Capital, KKR-linked Dawn and other major investors.

Atopic dermatitis affects up to 25% of children and 4% to 7% of adults. Common treatment for atopic dermatitis includes skin care routines like bathing and moisturizing. Most children outgrow atopic ...

Pfizer Inc. presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-to-severe atopic dermatitis (AD). The study met its primary endpoint ...

Study met primary endpoint, showing a statistically significant increase in the percentage of participants achieving EASI-75 versus placebo at Week 16, for the potentially first-in-class trispecific ...

Seborrheic dermatitis is a common skin condition that affects people of all races, but it can present unique challenges for Black Americans due to differences in hair texture, skin type, and cultural ...